ArticleMolecular diagnosis & therapy2011

Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers?

Arantza Fariña Sarasqueta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.